TINA DONALDSON: Open Payments
NPI 1376934174 · WINNETKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 56 payments from 8 companies in 2025. Trend: 2023 $261 · 2024 $602 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 36 | $184 |
| Lilly USA, LLC | 6 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Novo Nordisk Inc | 4 | $68 |
| SHIELD THERAPEUTICS INC | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: REPATHA, MOUNJARO, Kerendia, ACCRUFER, TZIELD, Wegovy, CAPVAXIVE, OTEZLA.
Industry payments across CA — which companies pay providers there.
